Items where Author is "Selmaj, K."
Number of items: 3. 2015Kappos, L. and Mehling, M. and Arroyo, R. and Izquierdo, G. and Selmaj, K. and Curovic-Perisic, V. and Keil, A. and Bijarnia, M. and Singh, A. and von Rosenstiel, P.. (2015) Randomized trial of vaccination in fingolimod-treated patients with multiple sclerosis. Neurology, 84 (9). pp. 872-879. 2008Garren, H. and Robinson, W. H. and Krasulova, E. and Havrdova, E. and Nadj, C. and Selmaj, K. and Losy, J. and Nadj, I. and Radue, E. W. and Kidd, B. A. and Gianettoni, J. and Tersini, K. and Utz, P. J. and Valone, F. and Steinman, L.. (2008) Phase 2 trial of a DNA vaccine encoding myelin basic protein for multiple sclerosis. Annals of neurology, Vol. 63, H. 5. pp. 611-620. Polman, C. and Kappos, L. and Freedman, M. S. and Edan, G. and Hartung, H. P. and Miller, D. H. and Montalbán, X. and Barkhof, F. and Selmaj, K. and Uitdehaag, B. M. and Dahms, S. and Bauer, L. and Pohl, C. and Sandbrink, R. and Benefit, investigators. (2008) Subgroups of the BENEFIT study : risk of developing MS and treatment effect of interferon beta-1b. Journal of neurology, Vol. 255, H. 4. pp. 480-487. |
